BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8193420)

  • 1. Ondansetron for treating nausea and vomiting in the poisoned patient.
    Reed MD; Marx CM
    Ann Pharmacother; 1994 Mar; 28(3):331-3. PubMed ID: 8193420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
    Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
    J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Ondansetron for treating nausea and vomiting in the poisoned patient.
    Forster ER; Palmer JL
    Ann Pharmacother; 1994 Oct; 28(10):1203-4. PubMed ID: 7841589
    [No Abstract]   [Full Text] [Related]  

  • 4. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity.
    Sage TA; Jones WN; Clark RF
    Ann Pharmacother; 1993 May; 27(5):584-5. PubMed ID: 8347909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
    Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
    Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
    Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F
    J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of treating and preventing nausea and vomiting in patients receiving chemotherapy.
    Stewart DJ; Dahrouge S; Coyle D; Evans WK
    J Clin Oncol; 1999 Jan; 17(1):344-51. PubMed ID: 10458253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions.
    Joslyn AF
    Anaesthesia; 1994 Jan; 49 Suppl():34-7. PubMed ID: 7907459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index).
    Tanneberger S; Lelli G; Martoni A; Piana E; Pannuti F
    J Chemother; 1992 Oct; 4(5):326-31. PubMed ID: 1479424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.
    Larijani GE; Gratz I; Afshar M; Minassian S
    Anesth Analg; 1991 Sep; 73(3):246-9. PubMed ID: 1831015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
    Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI
    Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication.
    Tobias JD; Gregory DF; Deshpande JK
    Pediatr Emerg Care; 1992 Dec; 8(6):345-6. PubMed ID: 1360651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
    Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.